Elgan Pharma is a company headquartered in Israel.
Elgan Pharma is a late-stage neonatology-focused biotech company developing safe, non-invasive therapies for preterm infants to address complications related to prematurity, including treatments for intestinal malabsorption and prevention of vision impairment due to retinopathy of prematurity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.